Global Dyslexia Market


Product Code: GH02441I Industry: Region:

Dyslexia is a learning disability in reading. People with dyslexia have trouble reading at a good pace and without mistakes. They may also have a hard time with reading comprehension, spelling, and writing. The global dyslexia market is expected to increase by USD 11 billion, at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2028, according to the latest edition of the Global Dyslexia Market Report.

This industry report offers market estimates of the global market, followed by a detailed analysis of the category, type of dyslexia, end user, and region. The global market data on dyslexia can be segmented by category: treatment, diagnosis. According to the research, the treatment segment had the largest share in the global dyslexia market. Dyslexia market is further segmented by type of dyslexia: phonological dyslexia, surface dyslexia, others. In 2021, the phonological dyslexia segment made up the largest share of revenue generated by the dyslexia market. Based on end user, the dyslexia market is segmented into: specialty centers, home care, hospitals & clinics, others. On the basis of region, the dyslexia market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

The global dyslexia market is highly competitive. The key players in the dyslexia market include Eli Lilly and Company, GSK plc, Lingit AS, Lyfta Oy, Novartis AG, Pfizer Inc., Soli, Speechify Inc., Teva Pharmaceutical Industries Ltd.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
– Get a detailed picture of the Global Dyslexia Market
– Identify segments/areas to invest in over the forecast period in the Global Dyslexia Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.

Global Dyslexia Market

Interested in this report? Get your FREE sample now!
Global Dyslexia Market - Report Scope


Base Year


Forecast Year


CAGR (2022-2028)




Key Players

Eli Lilly and Company, GSK plc, Lingit AS, Lyfta Oy, Novartis AG, Pfizer Inc., Soli, Speechify Inc., Teva Pharmaceutical Industries Ltd.

Related Reports
Global Scar Management Market 2023

The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…

Want to customize this report?
The present report possesses the flexibility to be tailored to your specific needs. Our team of analysts and industry experts will collaborate directly with you to gain a comprehensive understanding of your requirements.
Scroll to Top

Download Free Sample - Global Dyslexia Market

Please fill out our form and we will get back to you.